| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
|
Lancet
|
2005
|
21.91
|
|
2
|
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
|
N Engl J Med
|
2005
|
20.72
|
|
3
|
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2007
|
9.80
|
|
4
|
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure.
|
N Engl J Med
|
2015
|
8.61
|
|
5
|
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
|
Lancet
|
2006
|
6.42
|
|
6
|
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.
|
J Am Coll Cardiol
|
2012
|
3.56
|
|
7
|
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
|
Eur Heart J
|
2006
|
3.55
|
|
8
|
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).
|
Circulation
|
2012
|
3.42
|
|
9
|
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
|
Eur Heart J
|
2005
|
2.74
|
|
10
|
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
|
J Am Soc Nephrol
|
2007
|
1.92
|
|
11
|
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
|
Int J Cardiol
|
2011
|
1.89
|
|
12
|
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
|
Circulation
|
2005
|
1.86
|
|
13
|
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
|
Eur Heart J
|
2007
|
1.65
|
|
14
|
Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.
|
Eur J Heart Fail
|
2008
|
1.62
|
|
15
|
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.
|
Eur J Heart Fail
|
2012
|
1.53
|
|
16
|
NT-pro-BNP for differential diagnosis in patients with syncope.
|
Int J Cardiol
|
2008
|
1.49
|
|
17
|
Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement.
|
Ann Thorac Surg
|
2011
|
1.48
|
|
18
|
Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure.
|
Eur J Heart Fail
|
2013
|
1.47
|
|
19
|
QT dispersion in comparison to Tl-201-SPECT for detection of myocardial ischaemia.
|
Int J Cardiol
|
2006
|
1.39
|
|
20
|
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation.
|
Cardiovasc Res
|
2003
|
1.38
|
|
21
|
The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.
|
Diabetes Care
|
2004
|
1.31
|
|
22
|
Local versus general anesthesia for transfemoral aortic valve implantation.
|
Clin Res Cardiol
|
2011
|
1.27
|
|
23
|
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.
|
Eur J Heart Fail
|
2012
|
1.19
|
|
24
|
Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.
|
Arch Intern Med
|
2006
|
1.14
|
|
25
|
Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
|
Clin Res Cardiol
|
2008
|
1.13
|
|
26
|
Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".
|
Eur J Heart Fail
|
2006
|
1.10
|
|
27
|
Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
|
PLoS One
|
2012
|
1.03
|
|
28
|
Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
|
Am Heart J
|
2008
|
1.02
|
|
29
|
Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
|
Diabetes
|
2008
|
1.02
|
|
30
|
MRI in patients with pacemakers: overview and procedural management.
|
Dtsch Arztebl Int
|
2012
|
1.01
|
|
31
|
Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
|
Circulation
|
2006
|
0.99
|
|
32
|
Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages.
|
Am J Respir Cell Mol Biol
|
2003
|
0.95
|
|
33
|
Local thrombolysis for successful treatment of acute stroke in an adolescent with cardiac myxoma.
|
ScientificWorldJournal
|
2011
|
0.92
|
|
34
|
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
|
J Card Fail
|
2008
|
0.91
|
|
35
|
Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolism.
|
PLoS One
|
2009
|
0.90
|
|
36
|
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure.
|
Diabetes Care
|
2007
|
0.89
|
|
37
|
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
|
Eur J Heart Fail
|
2010
|
0.89
|
|
38
|
A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.
|
Int J Cardiol
|
2011
|
0.89
|
|
39
|
Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.
|
Clin Res Cardiol
|
2009
|
0.89
|
|
40
|
Mortality in a cardiac intensive care unit.
|
Clin Res Cardiol
|
2012
|
0.88
|
|
41
|
Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy.
|
Clin Res Cardiol
|
2007
|
0.87
|
|
42
|
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox".
|
FASEB J
|
2002
|
0.87
|
|
43
|
The relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in cardiovascular patients.
|
Int J Cardiol
|
2009
|
0.85
|
|
44
|
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study.
|
Clin Res Cardiol
|
2011
|
0.85
|
|
45
|
Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.
|
Ann Intern Med
|
2003
|
0.84
|
|
46
|
Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine.
|
Eur J Clin Pharmacol
|
2010
|
0.84
|
|
47
|
Extensive hepatic portal venous gas and gastric emphysema after successful resuscitation.
|
Resuscitation
|
2010
|
0.83
|
|
48
|
Magnetic resonance imaging of carcinoid heart disease.
|
Clin Cardiol
|
2009
|
0.82
|
|
49
|
Impaired TNFalpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAPkinases and histone acetylation--effect of dexamethasone.
|
Cell Biochem Biophys
|
2007
|
0.82
|
|
50
|
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective.
|
Cost Eff Resour Alloc
|
2009
|
0.81
|
|
51
|
The problem of polypharmacy in heart failure.
|
Curr Cardiol Rep
|
2006
|
0.81
|
|
52
|
Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.
|
PLoS One
|
2010
|
0.80
|
|
53
|
Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension.
|
Int J Cardiol
|
2011
|
0.80
|
|
54
|
IL-12-induced T-bet expression and IFNgamma release in lymphocytes from asthmatics--role of MAPkinases ERK-1/-2, p38(MAPK) and effect of dexamethasone.
|
Respir Med
|
2006
|
0.80
|
|
55
|
Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).
|
Cardiovasc Drugs Ther
|
2011
|
0.80
|
|
56
|
Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
|
Cardiovasc Res
|
2008
|
0.80
|
|
57
|
NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope.
|
Int J Cardiol
|
2010
|
0.79
|
|
58
|
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.
|
Clin Res Cardiol
|
2010
|
0.79
|
|
59
|
Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection.
|
Case Rep Med
|
2010
|
0.79
|
|
60
|
Continuous central haemodynamic measurements during the six-minute walk test and daily life in patients with chronic heart failure.
|
Eur J Heart Fail
|
2009
|
0.79
|
|
61
|
Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study.
|
Clin Res Cardiol
|
2010
|
0.79
|
|
62
|
Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial.
|
J Atheroscler Thromb
|
2010
|
0.79
|
|
63
|
Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics.
|
Clin Immunol
|
2007
|
0.78
|
|
64
|
ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting.
|
Clin Res Cardiol
|
2008
|
0.78
|
|
65
|
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)".
|
Circulation
|
2013
|
0.77
|
|
66
|
Diabetes-related defects in sarcoplasmic Ca2+ release are prevented by inactivation of G(alpha)11 and G(alpha)q in murine cardiomyocytes.
|
Mol Cell Biochem
|
2010
|
0.77
|
|
67
|
[Novel indications for phosphodiesterase type 5 inhibitors].
|
Med Klin (Munich)
|
2007
|
0.77
|
|
68
|
Informed consent prior to coronary angiography in a real world scenario: what do patients remember?
|
PLoS One
|
2010
|
0.77
|
|
69
|
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study.
|
Diab Vasc Dis Res
|
2010
|
0.77
|
|
70
|
Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry.
|
BMC Cardiovasc Disord
|
2014
|
0.77
|
|
71
|
Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction?
|
Eur J Cardiovasc Prev Rehabil
|
2011
|
0.77
|
|
72
|
Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction.
|
Int J Cardiol
|
2010
|
0.77
|
|
73
|
The G protein Gα11 is essential for hypertrophic signalling in diabetic myocardium.
|
Int J Cardiol
|
2012
|
0.76
|
|
74
|
[Implementation of recommendations for the diagnosis of heart failure].
|
Dtsch Med Wochenschr
|
2010
|
0.75
|
|
75
|
Conservative management of Candida infection of prosthetic aortic graft by means of caspofungin and fluconazole alone.
|
Tex Heart Inst J
|
2011
|
0.75
|
|
76
|
[68-year-old patient with exercise-induced syncope].
|
Dtsch Med Wochenschr
|
2010
|
0.75
|
|
77
|
[Politics and medicine in the 21st century--misunderstandings, insolvency or foolishness?].
|
Herz
|
2003
|
0.75
|
|
78
|
[Coronary Heart Disease: Advances in Diagnostics and Therapy].
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
79
|
[PDE5 inhibitors in the treatment of pulmonary hypertension].
|
Pharm Unserer Zeit
|
2010
|
0.75
|
|
80
|
[The cardiology standard is no flash in the pan. Conversation with Prof. Erland Erdmann, Köln].
|
Herz
|
2005
|
0.75
|
|
81
|
[Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
|
Med Klin (Munich)
|
2007
|
0.75
|
|
82
|
[Interview with Prof. Erland Erdmann, Cologne. Oral antidiabetic with protective effect].
|
MMW Fortschr Med
|
2006
|
0.75
|
|
83
|
[The Takotsubo syndrome--a psychosomatic cardiac complication?].
|
MMW Fortschr Med
|
2007
|
0.75
|
|
84
|
[Racing heart and angina pectoris in a 19-year-old male. Possibly the result of cannabis smoking?].
|
MMW Fortschr Med
|
2004
|
0.75
|
|
85
|
[Diabetes and heart failure].
|
Herz
|
2010
|
0.75
|
|
86
|
Case studies: reducing risk in patients with diabetes.
|
Drugs Today (Barc)
|
2006
|
0.75
|
|
87
|
[Early diagnosis - successful treatment].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
88
|
Pneumomediastinum and striking family history: uncommon case of Birt-Hogg-Dubé syndrome.
|
Intern Med
|
2012
|
0.75
|
|
89
|
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
|
Cardiovasc Ther
|
2011
|
0.75
|
|
90
|
Rare cause for sudden right heart failure.
|
ScientificWorldJournal
|
2010
|
0.75
|
|
91
|
[Subclinical thrombosis is a possible risk factor for apoplexy].
|
Dtsch Med Wochenschr
|
2015
|
0.75
|
|
92
|
[Suspected heart failure: how important is the BNP-testing for the general practitioner?].
|
MMW Fortschr Med
|
2009
|
0.75
|
|
93
|
[79-year-old patient with paroxysmal artial fibrillation and syncope].
|
Dtsch Med Wochenschr
|
2009
|
0.75
|
|
94
|
[25 years of progress in cardiology--heart failure: from haemodynamics to neuroendocrinology].
|
MMW Fortschr Med
|
2008
|
0.75
|
|
95
|
Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.
|
Int J Cardiol
|
2011
|
0.75
|
|
96
|
[Detached point of a thin lumen thorax drainage tube in the right lung].
|
Dtsch Med Wochenschr
|
2008
|
0.75
|
|
97
|
Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study.
|
J Rheumatol
|
2006
|
0.75
|
|
98
|
[Do the best physicians work only for private patients? No, for bureaucracy!].
|
MMW Fortschr Med
|
2004
|
0.75
|
|
99
|
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
|
Eur J Heart Fail
|
2004
|
0.75
|
|
100
|
[Diabetes mellitus and heart failure: epidemiology and therapy].
|
Herz
|
2008
|
0.75
|